ITRI LORETTTA M enters IMMUNOMEDICS INC with 15K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/18/2020ACC: 0001104659-20-022513
Officer· Chief Medical Officer
Since Feb 2020
15K
Baseline shares
100% direct
15K
Direct ownership
1 position
70K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, par value $0.01 per share
DirectShares owned15K
Total
15K direct15K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.01 per share | 15K | Direct |
| Total | 15K | 15K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock, par value $0.01 per share
Underlying shares
20K
Shares owned
N/A
Exercise price
12.48
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock, par value $0.01 per share
Underlying shares
50K
Shares owned
N/A
Exercise price
14.35
Expiration
—
Exercise window
—
Total
Underlying
70K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock, par value $0.01 per share | 12.48 | — | — | 20K | N/A |
| Stock Option (right to buy) Direct | Common Stock, par value $0.01 per share | 14.35 | — | — | 50K | N/A |
| Total | 70K | 0.00 | ||||